Valuation: Monto Minerals Ltd

Market Cap 4.13Cr 2.88Cr 2.52Cr 2.32Cr 2.14Cr 4.04Cr 277.6Cr 28Cr 11Cr 135.96Cr 11Cr 11Cr 468.02Cr P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 4.13Cr 2.88Cr 2.52Cr 2.32Cr 2.14Cr 4.04Cr 277.43Cr 28Cr 11Cr 135.87Cr 11Cr 11Cr 467.74Cr EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
-1.01%+2.77%-29.33%-5.55% 3.17TCr
-3.46%-5.05%-43.38%+183.84% 1.36TCr
-1.43%-2.55%-24.35%+66.69% 550.1Cr
-4.20%-6.89% - - 214.57Cr
-2.40%+2.11%+64.00%-35.71% 208.61Cr
-0.73%-5.34% - - 173.83Cr
-4.23%-2.47%-38.47% - 106.54Cr
-3.80%-5.00%+45.22%+102.67% 90Cr
-6.74%-2.64%-41.45%-56.77% 76Cr
Average -3.11%-2.78%-9.68%+42.53% 662.04Cr
Weighted average by Cap. -1.94%-0.40%-27.92%+48.96%

Financials

2024 2025
Net sales 4L 3L 2L 2L 2L 4L 2.67Cr 26.76L 10.53L 1.31Cr 10.43L 10.2L 4.51Cr 3L 2L 2L 2L 2L 3L 2.17Cr 21.67L 9L 1.06Cr 8L 8L 3.65Cr
Net income -31.3L -21.86L -19.1L -17.63L -16.25L -30.62L -21Cr -2.11Cr -82.87L -10Cr -82.09L -80.29L -35Cr -14.48L -10.11L -9L -8L -8L -14.16L -9.74Cr -97.44L -38.33L -4.77Cr -37.97L -37.13L -16Cr
Net Debt -4L -3L -2L -2L -2L -4L -2.52Cr -25.22L -10L -1.23Cr -10L -10L -4.25Cr -25.17T -17.57T -15.36T -14.17T -13.06T -24.62T -16.92L -2L -66.62T -8L -65.99T -64.55T -28.53L
Logo Monto Minerals Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-